Roles of stem cells in tissue turnover and radiation carcinogenesis

Radiation Research

Volumn 174, Issue 6 B, 2010, Pages 833-839

  Niwa, Ohtsura ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; BLASTOCYST; CALCULATION; CANCER RISK; CARCINOGENESIS; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; HEMATOPOIETIC STEM CELL; HUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION PROTECTION; REVIEW; STEM CELL; TARGET CELL; TISSUE METABOLISM;

ADULT; AGE FACTORS; ANIMALS; FETUS; HUMANS; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; RADIATION DOSAGE; RISK; STEM CELLS;

EID: 78649998516     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1970.1     Document Type: Review

References (56)

1. ICRP, 2007 Recommendations of the International Commission on Radiological Protection. Publication 103, Annals of the ICRP, Vol. 37, Nos. 2-4, Elsevier, Amsterdam, 2007.
2. E. S. Gilbert, Ionising radiation and cancer risks: What have we learned from epidemiology? Int. J. Radiat. Biol. 85, 467-482 (2009).
3. D. L. Preston, S. Kusumi, M. Tomonaga, S. Izumi, E. Ron, A. Kuramoto, N. Kamada, H. Dohy, T. Matsuo and K. Mabuchi, Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat. Res. 137 (Suppl.), S68-S97 (1994).
4. D. L. Preston, D. A. Pierce, Y. Shimizu, H. M. Cullings, S. Fujita, S. Funamoto and K. Kodama, Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat. Res. 162, 377-389 (2004).
5. D. E. Thompson, K. Mabuchi, E. Ron, M. Soda, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda, M. Terasaki and D. L. Preston, Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat. Res. 137, S17-S67 (1994).
6. D. L. Preston, E. Ron, S. Tokuoka, S. Funamoto, N. Nishi, M. Soda, K. Mabuchi and K. Kodama, Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat. Res. 168, 1-64 (2007).
7. National Research Council, Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. National Academies Press, Washington, DC, 2006.
8. R. Wakeford and M. P. Little, Risk coefficients for childhood cancer after intrauterine irradiation: a review. Int. J. Radiat. Biol. 79, 293-309 (2003).
9. J. D. Boice, Jr. and R. W. Miller, Childhood and adult cancer after intrauterine exposure to ionizing radiation. Teratology 59, 227-233 (1999).
10. D. L. Preston, H. Cullings, A. Suyama, S. Funamoto, N. Nishi, M. Soda, K. Mabuchi, F. Kasagi and R. E. Shore, Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J. Natl. Cancer Inst. 100, 428-436 (2008).
11. M. P. Little, W. F. Heidenreich, S. H. Moolgavkar, H. Schöllnberger and D. C. Thomas, Systems biological and mechanistic modelling of radiation-induced cancer. Radiat. Environ. Biophys. 47, 39-47 (2008).
12. T. Reya, D. J. Morrison, M. F. Clarke and I. L. Weissman, Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (2001).
13. M. J. Evans and M. H. Kaufman, Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156 (1981).
14. G. R. Martin, Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78, 7634-7638 (1981).
15. L. Armstrong, M. Lako, J. Lincoln, P. M. Cairns and N. Hole, mTert expression correlates with telomerase activity during the differentiation of murine embryonic stem cells. Mech. Dev. 97, 109-116 (2000).
16. C. S. Potten, R. B. Clarke, J. Wilson and A. G. Renehan, Eds., Tissue Stem Cells. Taylor & Francis, London, 2006.
17. D. G. Phinney and D. J. Prockop, Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 25, 2896-2902 (2007).
18. F. Arai and T. Suda, Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann. NY Acad. Sci. 1106, 41-53 (2007).
19. N. Barker, J. H. van Es, J. Kuipers, P. Kujala, M. van den Born, M. Cozijnsen, A. Haegebarth, J. Korving, H. Begthel and H. Clevers, Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-1007 (2007).
20. E. Sangiorgi and M. R. Capecchi, Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 40, 915-920 (2008).
21. K. L. Spalding, E. Arner, P. O. Westermark, S. Bernard, B. A. Buchholz, O. Bergmann, L. Blomqvist, J. Hoffstedt, E. Naslund and P. Arner, Dynamics of fat cell turnover in humans. Nature 453, 783-787 (2008).
22. K. L. Spalding, R. D. Bhardwaj, B. A. Buchholz, H. Druid and J. Frisen, Retrospective birth dating of cells in humans. Cell 122, 133-143 (2005).
23. C. Cobaleda, C. W. Jochum and M. Busslinger, Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 449, 473-477 (2007).
24. K. Takahashi and S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
25. B. Coiffier, Rituximab therapy in malignant lymphoma. Oncogene 26, 3603-3613 (2007)
26. L. F. Drynan, R. Pannell, A. Forster, N. M. Chan, F. Cano, A. Daser and T. H. Rabbitts, Mll fusions generated by Cre-loxPmediated de novo translocations can induce lineage reassignment in tumorigenesis. EMBO J. 24, 3136-3146 (2005).
27. N. Barker, R. A. Ridgway, J. H. van Es, M. van de Wetering, H. Begthel, M. van den Born, E. Danenberg, A. R. Clarke, O. L. Sansom and H. Clevers, Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608-611 (2009).
28. N. Bakers, M. van de Wetering and H. Clevers, The intestinal stem cells. Genes Dev. 22, 1856-1864 (2008).
29. C. S. Potten, R. Gandara, Y. R. Mahida, M. Loeffler and N. A. Wright, The stem cells of small intestinal crypts: where are they? Cell Prolif. 42, 731-750 (2009).
30. E. Clayton, D. P. Doupé , A. M. Klein, D. J. Winton, B. D. Simons and P. H. Jones, A single type of progenitor cell maintains normal epidermis. Nature 446, 185-189 (2007).
31. P. H. Jones, B. D. Simons and F. M. Watt, Sic transit gloria: farewell to the epidermal transit amplifying cell? Cell Stem Cell 1, 371-381 (2007).
32. P. Armitage and R. Doll, The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer 8, 1-12 (1954).
33. D. A. Pierce and M. L. Mendelsohn, A model for radiationrelated cancer suggested by atomic bomb survivor data. Radiat Res. 52, 642-654 (1999).
34. D. A. Pierce and M. Vaeth, Age-time patterns of cancer to be anticipated from exposure to general mutagens. Biostatistics 4, 231-248 (2003).
35. L. Tomasek, A. Rogel, M. Tirmarche, N. Mitton and D. Laurier, Lung cancer in French and Czech uranium miners: Radonassociated risk at low exposure rates and modifying effects of time since exposure and age at exposure. Radiat. Res. 169, 125-137 (2008).
36. M. F. Lyon, D. G. Papworth and R. J. Phillips, Dose-rate and mutation frequency after irradiation of mouse spermatogonia. Nat. New Biol. 238, 101-104 (1972).
37. W. L. Russell and E. M. Kelly, Specific-locus mutation frequencies in mouse stem-cell spermatogonia at very low radiation dose rates. Proc. Natl. Acad. Sci. USA 79, 539-541 (1982).
38. A. G. Searle, Mutation induction in mice. Adv. Radiat. Biol. 4, 131-207 (1974).
39. A. G. Searle, C. V. Beechey, D. Green and E. R. Humphreys, Cytogenetic effects of protracted exposures to alpha-particle from Pu-239 and to gamma-rays from Co-60 compared in male mice. Mutat. Res. 41, 297-310 (1976).
40. I. Tobari, Y. Matsuda, X. H. Gu, J. Yamagiwa, T. Utsugi, M. Kitazume and M. Okamoto, Dose-response relationship for translocation induction in spermatogonia of the crab-eating monkey (Macaca fascicularis) by chronic gamma-ray-irradiation. Mutat. Res. 201, 81-87 (1988).
41. R. J. Preston and J. G. Brewen, X-ray induced translocations in spermatogonia. I. Dose and fractionation responses in mice. Mutat. Res. 19, 215-223 (1973).
42. K. Tanaka, A. Kohda, K. Satoh, T. Toyokawa, K. Ichinohe, M. Ohtaki and Y. Oghiso, Dose-rate effectiveness for unstable-type chromosome aberrations detected in mice after continuous irradiation with low-dose-rate gamma rays. Radiat Res. 171, 290-301 (2009).
43. K. Kamiya, A. Inoh, Y. Fujii, K. Kanda, T. Kobayashi and K. Yokoro, High mammary carcinogenicity of neutron irradiation in rats and its promotion by prolactin. Jpn. J. Cancer Res. 76, 449-456 (1985).
44. T. Tsukamoto, K. Kozaki, Y. Nishikawa, M. Yamamoto, H. Fukami, M. Inoue, K. Wakabayashi and M. Tatematsu, Development and distribution of 2-amino-1-methyl-6-phenylimidazo[4,5- b] pyridine (PhIP)-induced aberrant crypt foci in the rat large intestine. Jpn. J. Cancer Res. 90, 720-725 (1999).
45. ICRP, Biological Effects after Prenatal Irradiation (Embryo and Fetus). Publication 90, Annals of the ICRP, Vol. 33, Nos. 1-2, Pergamon, London, 2003.
46. S. Sasaki, Influence of the age of mice at exposure to radiation on life-shortening and carcinogenesis. J. Radiat. Res. 32 (Suppl. 2), 73-85 (1991).
47. A Cumano and I. Godin, Ontogeny of the hematopoietic system. Ann. Res. Immunol. 25, 745-785 (2007).
48. I. M. Samokhvalov, N. I. Samokhvalova and S. Nishikawa, Cell tracing shows the contribution of the yolk sac to adult haematopoiesis. Nature 446, 1056-1061 (2007).
49. R. R. Delongchamp, K. Mabuchi, Y. Yoshimoto and D. L. Preston, Cancer mortality among atomic bomb survivors exposed in utero or as young children, October 1950-May 1992. Radiat. Res. 147, 385-395 (1997).
50. K. Ohtaki, Y. Kodama, M. Nakano, M. Itoh, A. A. Awa, J. Cologne and N. Nakamura, Human fetuses do not register chromosome damage inflicted by radiation exposure in lymphoid precursor cells except for a small but significant effect at low doses. Radiat. Res. 161, 373-379 (2004).
51. M. Nakano, Y. Kodama, K. Ohtaki, E. Nakashima, O. Niwa, M. Toyoshima and N. Nakamura, Chromosome aberrations do not persist in the lymphocytes or bone marrow cells of mice irradiated in utero or soon after birth. Radiat. Res. 167, 693- 702 (2007)
52. M. B. Bowie, K. D. McKnight, D. G. Kent, L. McCaffrey, P. A. Hoodless and C. J. Eaves, Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect. J. Clin. Invest. 116, 2808-2816 (2006).
53. N. Nakamura, A hypothesis: Radiation-related leukemia is mainly attributable to the small number of people who carry pre-existing clonally expanded preleukemic cells. Radiat. Res. 163, 258-265 (2005).
54. H. Mori, S. M. Colman, Z. Xiao, A. M. Ford, L. E. Healy, C. Donaldson, J. M. Hows, C. Navarrete and M. Greaves, Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc. Natl. Acad. Sci. USA 99, 8242-8247 (2002).
55. D. M. Parkins, L. L. Whelan, J. Ferlay, L. Teppo and D. B. Thomas, Eds., Cancer Incidence in Five Continents, Vol. VIII. Scientific Publication No. 155, IARC, Lyon, 2002.
56. L. A. G. Ries, M. A. Smith, J. G. Gurney, M. Linet, T. Tamra, J. L. Young and G. R. Bunin, Eds., Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. NIH Publication No. 99 4649, National Institutes of Health, Bethesda, MD, 1999.